Business Wire

Business Wire is a trusted partner to hundreds of Health, Medical, Biotech and Pharmaceutical companies and organizations throughout the world, delivering more corporate news releases from more sources to more destinations than any other service.

Business Wire's news wire circuits enable you to target your news to select audiences based on your geographic and industry market needs. In fact, Business Wire's delivery network is composed of some 60 news agencies, financial and information providers and web-based news services around the globe. From delivery to audiences in a single city to comprehensive worldwide coverage including translations, Business Wire offers you an easy, one-stop solution.

For additional information email tradeshow@businesswire.com or visit www.businesswire.com

Back to top

De Facto Communications

De Facto Communications is the consultancy of choice if you’re looking for the best in strategic communications in life science and healthcare. We have been leaders in our field since 1989 and our reputation for informed honest advice backed by effective service delivery is second to none. Being part of the Bell Pottinger Group - the UK’s largest communications consultancy, we offer large agency reach and real international influence. We are dedicated to giving you a clear advantage in today’s increasingly competitive marketplace.

For global pharmaceutical companies, the perceived value of their drug pipeline is increasingly critical to their corporate reputation. For smaller life science businesses, discovering and developing new drugs - where time to profitability is longer than in almost any other industry, reputation is entirely dependent on the credibility of management, the strength of the drug pipeline and the sustainability of the business model.

At De Facto we have a huge array of experience in brand-building communications – B2C, B2B and direct to stakeholder. We work with ambitious, ground-breaking companies to help them define the very essence of their brand, then manage the complexities of building its profile in this fluid and challenging marketplace.

De Facto already represents some of the world’s leading pharmaceutical, healthcare technology and medical device companies, providing strategic support and award-winning tactical implementation.

With their wide-ranging experience, we can create bespoke account teams that exactly match your markets, audiences and communications objectives.

This experience is underpinned by the ability to balance commercial, medical and regulatory environments with the attitudes and concerns of opinion leaders, patients and consumers, thereby creating awareness and bringing about changes in attitudes.

We have successfully helped a variety of businesses and organisations to achieve their goals - whether communicating the benefits of a new medical device to healthcare professionals or raising awareness of new genetic markers in cardiac disease to clinicians and the general public alike.

We have a dedicated team of experienced professionals who specialise in accelerating patient recruitment into our clients’ clinical studies. Working closely with clinical development teams we develop and manage direct-to-patient clinical trial recruitment and retention programmes.

Each programme is strategically developed through careful analysis of the study targets and demographics and is designed for implementation at local level. By utilising previous experience and identifying potential challenges to recruitment and retention in each country, we develop a unique programme that will work for every study.

Using marketing, advertising, PR and other communications tactics we not only encourage patients to participate in studies, but also support clinical investigators by maximising their motivation and making it easy for them to communicate clearly with patients.

Our access to the media, the financial community, government bodies, thought leaders and regulators usually exceeds our clients’ expectations. De Facto’s team is committed to working with you as a true business partner and to building long-term relationships whether you are based in the UK, Europe or the U.S.

www.defacto.com

back to top

Med Ad News

For more than 25 years, Med Ad News has provided the busy pharmaceutical executive with need-to-know business information.

Each issue delivers broad coverage and penetrating analysis of issues, events, trends, and strategies shaping the pharmaceutical industry. Published monthly, Med Ad News provides exclusive content examining historical trends pertaining to and current events affecting the sales and marketing of medicines and the companies that manufacture them.

To learn more about Med Ad News and other products from Canon Communications Pharmaceutical Media Group visit www.pharmalive.com or call 215-944-9800.

Back to top

Medical Device Developments

Medical Device Developments serves a growing international device industry now valued at over $160bn.

Each edition boasts a line-up of leading industry professionals covering the major themes and addressing the key issues currently shaping the market. 
By combining expert opinion with case studies and technical papers relating to every sector within the device industry, Medical Device Developments is designed to provide senior personnel within the major medical OEMs with the overview they need to lead the development of their organisation.

The publication is supported online by medicaldevice-network.com, a site used by the industry as a daily reference point covering current opinion and the latest developments as well providing a platform from which manufacturers can source suppliers and establish long-term supply partnerships.

For more details please visit medicaldevice-network.com

Back to top

Private Equity Insider

Plug In to Industry Secrets
Every week, Private Equity Insider reports on developments you’re not supposed to know about -- behind-the-scenes squabbles, hush-hush plans of investors and inside moves of buyout and venture capital funds. See for yourself by signing up for a three-week FREE trial subscription to Private Equity Insider. To start your no-risk trial, call 201-659-1700 or visit www.PEinsider.com.

Back to top

Richard Lewis Communications

Richard Lewis Communications, Inc. offers full service corporate and investor communications to therapeutically focused biotechnology companies in all stages of development.

Through our team of senior level counselors, we offer a deep understanding of our clients' business strategies. We specialize in designing programs related to strategic planning, investor relations, public and media relations, business development, patient advocacy outreach, and clinical trials recruitment strategies and execution.

Our strengths are combining our "hands-on" knowledge of drug development with concrete biotechnology and Wall Street experience - both on the client side and agency side. This unique combination enables us to provide our clients with more than 40 years of combined experience to develop a tactical communications program that addresses the unique needs of both private and public biotechnology companies seeking to increase their operational effectiveness.

For more information about RLC, visit www.rlcinc.com or call Gregory Tiberend, EVP & COO, at 212-827-0020.

Back to top

Russo Partners LLC

As the leading healthcare communications agency since 1988, first as Noonan Russo and now Russo Partners, we have a unique understanding of our clients’ businesses. Russo Partners’ highly experienced counselors know how to translate science and medicine into messages that resonate with a wide range of audiences.

Our clients include leaders in medical technology and devices, healthcare services, specialty pharmaceuticals, biotechnology and finance/venture capital worldwide.

Media Relationships
Russo Partners’ relationships with the media are second to none. Our media relations counselors are scientists, former journalists and experienced communicators whose reputation for knowledge and integrity leads journalists to us as their trusted sources time and time again.

Investor Relationships
Helping venture capitalists, bankers, analysts and portfolio managers to understand the value proposition of a client’s business – private or public – is a key component of our programs. With more than two decades of Wall Street experience, our investor relations counselors have built a vast network in healthcare finance.

Marketing Expertise
Russo Partners’ marketing communications counselors have launched major pharmaceuticals, medical devices, diagnostics tools and other products. Our brand building and sales support campaigns have won industry awards for their creativity and effectiveness. 

For more information see our website www.russopartnersllc.com or contact Tony Russo at tony.russo@russopartnersllc.com

Back to top

The Global Consulting Group

The Global Consulting Group is a leading international investor relations, corporate communications and public affairs consultancy, providing advisory services to publicly listed and private companies, non-profit organizations, and governments around the world. The firm’s focus is to enhance valuation, protect and strengthen corporate reputation and manage interactions with governments and regulators.

The Global Consulting Group has distinct, yet fully integrated, specialist teams that help clients solve issues and manage the day-to-day communications to an array of constituents: shareholders, investors, employees, communities, media, regulators and government officials.  We believe that our broad international reach and depth of experience, led by some of the industry’s most accomplished consultants, give our clients the power to effectively achieve their objectives. Our “hands-on” senior consultants are the principal interface with our clients, and we are unrelenting in our focus to deliver value.

Investor Relations and Financial Communications are inextricably linked in the mandate to promote and achieve shareholder value. Our financial communications services include strategic counsel, IR program support, message development, analytical research, targeting, road show coordination, financial media, and transaction communications.

The Corporate Communications practice provides counsel in reputation management, corporate positioning, crisis management, and communications to support a wide range of corporate transactions. Corporate communications services include business and trade media relations, corporate positioning, executive visibility, employee/internal communications, crisis communications, and transaction communications.

Many companies find it necessary to engage regulators and governments in a wide range of countries and jurisdictions. The Public Affairs practice provides expertise in strategic counsel, legislative monitoring and analysis, political process mapping, lobbying and management of lobbying campaigns, government procurement, outreach to policy makers, strategic alliance and advocacy building, and community relations.

The Global Consulting Group is headquartered in New York, with offices in Los Angeles, Sacramento, London, Edinburgh, Madrid, Brussels, Sao Paulo, Tel Aviv, Istanbul, Shanghai and Moscow. The Global Consulting Group is part of the largest independent PR company in the world, Huntsworth Financial (LSE: HNT) with over 60 principal offices in 30 countries.

www.hfgcg.com

back to top

GSAS Harvard Biotechnology Club

In the five years since the GSAS Harvard Biotechnology Club was founded by three former Harvard graduate students, the Club has grown to include over 2500 academic members and 1800 member from industry, including members from around the world. A central fixture in the Boston biotech community, the Biotech Club constantly strives to bridge the gap between industry, academia, and the general public on matters relating to biotechnology and its applications. The Club’s web-content and seminars cover the many facets of the biotechnology and pharmaceutical industry, as well as providing career assistance to its members. Many of the Club’s sponsors include top local biotech and pharmaceutical research firms, numerous intellectual property law and venture financing firms. The Club’s mission is to explore and raise awareness on every aspect of biotechnology.

www.thebiotechclub.org

Back to top